Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death

Cited by (825)

Items 301–400 of 825

1. Early repolarization and short QT interval in healthy subjects.
   G. Panicker, Deepa Manohar, D. Karnad, Vaibhav Salvi, Snehal N. Kothari, Y. Lokhandwala · 2012 · Heart Rhythm
2. Cellular Basis for Atrial Fibrillation in an Experimental Model of Short QT1: Implications for a Pharmacologic Approach to Therapy
   E. Nof, A. Burashnikov, C. Antzelevitch · 2009 · Heart Rhythm
3. Disease-causing mutations of calcium channels
   N. Lorenzon, K. Beam · 2008 · Channels
4. Brugada Syndrome: From Molecular Mechanisms and Genetics to Risk Stratification
   Irene Paula Popa, D. Șerban, M. Mărănducă, I. Șerban, B. Tamba, I. Tudorancea · 2023 · International Journal of Molecular Sciences
5. Role of Ca2+ in healthy and pathologic cardiac function: from normal excitation–contraction coupling to mutations that cause inherited arrhythmia
   Joshua A. Keefe, Oliver M. Moore, Kevin S. Ho, Xander H.T. Wehrens · 2022 · Archives of Toxicology
6. Pharmacoresponse in Genetic Generalized Epilepsy: A Genome-Wide Association Study
   Stefan Wolking, Herbert Schulz, Anne T. Nies, Mark McCormack, Elke Schaeffeler, Pauls Auce, Andreja Avberšek, Felicitas Becker, Karl Martin Klein, Martin Krenn et al. · 2020 · Pharmacogenomics
7. Brugada Syndrome and Exercise Practice: Current Knowledge, Shortcomings and Open Questions
   G. Mascia, E. Arbelo, Jaime hernández-Ojeda, Francesco Solimene, R. Brugada, J. Brugada · 2017 · International Journal of Sports Medicine
8. The Brugada Syndrome - From Gene to Therapy.
   A. Curcio, G. Santarpia, C. Indolfi · 2017 · Circulation Journal
9. Next-Generation Sequencing in Post-mortem Genetic Testing of Young Sudden Cardiac Death Cases
   N. Lahrouchi, E. Behr, C. Bezzina · 2016 · Frontiers in Cardiovascular Medicine
10. Regulation of high‐voltage‐activated Ca2+ channel function, trafficking, and membrane stability by auxiliary subunits
    Ricardo Felix, Aida Calderón‐Rivera, Arturo Andrade · 2013 · Wiley Interdisciplinary Reviews Membrane Transport and Signalling
11. Mechanisms of drug-induced proarrhythmia in clinical practice
    Arkadia Konstantopoulou · 2013 · World Journal of Cardiology
12. The short QT syndrome
    J. Hancox, M. McPate, Aziza E. L. Harchi, R. S. Duncan, C. Dempsey, Harry J. Witchel, I. Adeniran, Heng-Gui Zhang · 2011 · Journal of interventional cardiac electrophysiology
13. Chloroquine Blocks a Mutant Kir2.1 Channel Responsible for Short QT Syndrome and Normalizes Repolarization Properties in silico
    A. Lopez-Izquierdo, Daniela Ponce-Balbuena, Tania Ferrer, F. Sachse, M. Tristani-Firouzi, J. Sánchez-Chapula · 2009 · Cellular Physiology and Biochemistry
14. Identification of six novel SCN5A mutations in Japanese patients with Brugada syndrome.
    T. Nakajima, Y. Kaneko, A. Saito, T. Irie, S. Tange, T. Iso, M. Kurabayashi · 2011 · International Heart Journal
15. Dysfunction of the Voltage‐Gated K + Channel β2 Subunit in a Familial Case of Brugada Syndrome
    Vincent Portero, Solena Le Scouarnec, Zeineb Es‐Salah‐Lamoureux, Sophie Burel, Jean‐Baptiste Gourraud, Stéphanie Bonnaud, Pierre Lindenbaum, Floriane Simonet, Jade Violleau, Estelle Baron et al. · 2016 · Journal of the American Heart Association
16. Exercise restrictions for patients with inherited cardiac conditions: Current guidelines, challenges and limitations
    Matthew Hammond‐Haley, Riyaz S. Patel, Rui Andre Providencia, Pier David Lambiase · 2016 · International Journal of Cardiology
17. Next Generation Sequencing and Linkage Analysis for the Molecular Diagnosis of a Novel Overlapping Syndrome Characterized by Hypertrophic Cardiomyopathy and Typical Electrical Instability of Brugada Syndrome.
    R. Mango, A. Luchetti, R. Sangiuolo, Valentina Ferradini, N. Briglia, E. Giardina, F. Ferrè, Manuela Helmer Citterich, F. Romeo, G. Novelli et al. · 2016 · Circulation Journal
18. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations
    D. Béziau, J. Barc, Thomas O'Hara, L. Le Gloan, M. Amarouch, A. Solnon, D. Pavin, S. Lecointe, P. Bouillet, J. Gourraud et al. · 2014 · Basic Research in Cardiology
19. Arrhythmias in primary hyperparathyroidism evaluated by exercise test
    Jessica Pepe, Mario Curione, Sergio Morelli, Marco Colotto, Marisa Varrenti, Claudia Castro, Antonella D’Angelo, Cristiana Cipriani, Sara Piemonte, Elisabetta Romagnoli et al. · 2012 · European Journal of Clinical Investigation
20. Rapid genetic testing facilitating the diagnosis of short QT syndrome.
    C. Redpath, M. Green, D. Birnie, M. Gollob · 2009 · Canadian Journal of Cardiology
21. Cannabidiol inhibits multiple cardiac ion channels and shortens ventricular action potential duration in vitro
    Marguerite Le Marois, Véronique Ballet, Camille Sanson, Magali-Anne Maizières, Thierry Carriot, Céline Chantoiseau, Michel Partiseti, Georg Andrees Böhme · 2020 · European Journal of Pharmacology
22. Long-term follow-up of implantable cardioverter-defibrillators in Short QT syndrome
    I. El-Battrawy, J. Besler, U. Ansari, V. Liebe, R. Schimpf, E. Tülümen, B. Rudic, S. Lang, K. Odening, Lukas Cyganek et al. · 2019 · Clinical Research in Cardiology
23. Molecular and Functional Characterization of Rare CACNA1C Variants in Sudden Unexplained Death in the Young.
    Brittan S Sutphin, N. Boczek, H. Barajas-Martinez, Dan Hu, D. Ye, D. Tester, C. Antzelevitch, M. Ackerman · 2016 · Congenital Heart Disease
24. Electrocardiographic Manifestations of Calcium Abnormalities
    E. Chorin, R. Rosso, S. Viskin · 2016 · Annals of Noninvasive Electrocardiology
25. Brugada syndrome and its relevance in the perioperative period
    F. Mookadam, D. Sorajja, H. Ramakrishna, AKarl Poterack, W. Shen · 2015 · Annals of Cardiac Anaesthesia
26. Genetics of Cardiac Electrical Disease
    Mark J. Perrin, Michael H. Gollob · 2012 · Canadian Journal of Cardiology
27. Genetic and clinical aspects of Brugada syndrome: an update.
    G. Lippi, M. Montagnana, T. Meschi, I. Comelli, G. Cervellin · 2012 · Advances in Clinical Chemistry
28. FGF12: biology and function
    Martyna Biaduń, Radosław Karelus, Daniel Krowarsch, Łukasz Opaliński, Małgorzata Zakrzewska · 2023 · Differentiation
29. In silico investigation of a KCNQ1 mutation associated with short QT syndrome
    I. Adeniran, Dominic G. Whittaker, Aziza E. L. Harchi, J. Hancox, Heng-Gui Zhang · 2017 · Scientific Reports
30. Effects of L-type calcium channel and human ether-a-go-go related gene blockers on the electrical activity of the human heart: a simulation study
    N. Zemzemi, B. Rodríguez · 2014 · Europace
31. Short QT Syndrome: A Predictable Story
    J. Brugada, I. Gussak, P. Brugada · 2014 · The Cardiology
32. Nonsense-mediated mRNA decay due to a CACNA1C splicing mutation in a patient with Brugada syndrome.
    M. Fukuyama, S. Ohno, Qi Wang, T. Shirayama, H. Itoh, M. Horie · 2014 · Heart Rhythm
33. Ca2+ channel and Na+/Ca2+ exchange localization in cardiac myocytes
    David R.L. Scriven, Edwin D.W. Moore · 2012 · Journal of Molecular and Cellular Cardiology
34. Short QT Syndrome: A Review
    Umang Patel, B. Pavri · 2009 · Cardiology in Review
35. Genetic analysis identifies the SLC4A3 anion exchanger as a major gene for short QT syndrome.
    M. Christiansen, K. Kjaer-Sorensen, N. Clavsen, S. Dittmann, Maja Fuhlendorff Jensen, H. Guldbrandsen, L. N. Pedersen, Rikke Hasle Sørensen, D. Lildballe, Klara Müller et al. · 2023 · Heart Rhythm
36. Multiple clinical profiles of families with the short QT syndrome.
    D. Akdis, A. Saguner, A. Medeiros-Domingo, André Schaller, Christian Balmer, J. Steffel, C. Brunckhorst, F. Duru · 2018 · Europace
37. Brugada Syndrome: A Heterogeneous Disease with a Common ECG Phenotype?
    B. Gray, C. Semsarian, R. Sy · 2014 · Cardiovascular Electrophysiology
38. Sodium current and potassium transient outward current genes in Brugada syndrome: screening and bioinformatics.
    A. Holst, S. Saber, M. Houshmand, E. Zaklyazminskaya, Yinman Wang, H. Jensen, L. Refsgaard, S. Haunsø, J. Svendsen, M. Olesen et al. · 2012 · Canadian Journal of Cardiology
39. Exercise extreme caution when calling rare genetic variants novel arrhythmia syndrome susceptibility mutations.
    A. Wilde, M. Ackerman · 2010 · Heart Rhythm
40. Cardiac Repolarisation and Drug Regulation
    Rashmi R. Shah · 2007 · Drug Safety
41. Genetic and Molecular Mechanisms in Brugada Syndrome
    E. Moras, K. Gandhi, B. Narasimhan, R. Brugada, J. Brugada, P. Brugada, C. Krittanawong · 2023 · Cells
42. Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization
    Kevin Richard Bersell, Tao Yang, Jonathan D. Mosley, Andrew Michael Glazer, Andrew T. Hale, Dmytro O. Kryshtal, Kyungsoo Kim, Jeffrey D. Steimle, Jonathan D. Brown, Joe‐Elie Salem et al. · 2022 · Circulation
43. Precision Medicine Approaches to Cardiac Arrhythmias
    John R. Giudicessi, Michael John Ackerman, Diane Fatkin, Jason Ciril Kovacic · 2021 · Journal of the American College of Cardiology
44. Inherited Cardiac Arrhythmias and Channelopathies.
    J. Kline, O. Costantini · 2019 · The Medical clinics of North America
45. A pore-localizing CACNA1C-E1115K missense mutation, identified in a patient with idiopathic QT prolongation, bradycardia, and autism spectrum disorder, converts the L-type calcium channel into a hybrid nonselective monovalent cation channel.
    D. Ye, D. Tester, Wei Zhou, J. Papagiannis, M. Ackerman · 2019 · Heart Rhythm
46. Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression
    M. Eden, B. Meder, M. Völkers, M. Poomvanicha, Katrin Domes, M. Branchereau, P. Marck, R. Will, A. Bernt, A. Rangrez et al. · 2016 · Nature Communications
47. Improved understanding of the pathophysiology of atrial fibrillation through the lens of discrete pathological pathways
    Muhammad Adnan Balouch, Matthew J. Kolek, Dawood Darbar · 2014 · Global Cardiology Science and Practice
48. Chinese herbal medicine for the treatment of cardiovascular diseases ─ Targeting cardiac ion channels
    Zhenzhen Yan, Ling Zhong, Wandi Zhu, Sookja Kim Chung, Panpan Hou · 2023 · Pharmacological Research
49. Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study
    Cun-Jin Luo, Kuan-Quan Wang, Heng-Gui Zhang · 2017 · BioMedical Engineering OnLine
50. Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutations
    Chia‐Hsiang Hsueh, Wen‐Pin Chen, Jiunn-Lee Lin, Chia‐Ti Tsai, Yen‐Bin Liu, Jyh‐Ming Jimmy Juang, Hsuan-Ming Tsao, Ming‐Jai Su, Ling‐Ping Lai · 2009 · Journal of Biomedical Science
51. Risk Stratification and Treatment of Brugada Syndrome
    E. Arbelo, J. Brugada · 2014 · Current Cardiology Reports
52. Genetics of Sudden Cardiac Death
    Alon Barsheshet, andrew J. brenyo, Arthur J. Moss, Ilan Goldenberg · 2011 · Current Cardiology Reports
53. Strategy for clinical evaluation and screening of sudden cardiac death relatives
    Laura Ferrero‐Miliani, Anders Gaarsdal Holst, Steen Michael Pehrson, Niels Morling, Henning Bundgaard · 2010 · Fundamental and Clinical Pharmacology
54. Congenital short QT syndrome: landmarks of the newest arrhythmogenic cardiac channelopathy.
    A. R. Pérez Riera, Adail Paixão-Almeida, Raimundo Barbosa-Barros, F. Yanowitz, A. Baranchuk, S. Dubner, Antônio Carlos Palandri Chagas · 2013 · Cardiology Journal
55. Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome
    Yaxun Sun, Jun Su, Xiaochen Wang, Jue Wang, Fengfeng Guo, Hangyuan Qiu, Hangping Fan, Dongsheng Cai, Hao Wang, Miao Lin et al. · 2023 · EBioMedicine
56. Short QT Syndrome
    C. Wolpert, C. Veltmann, Rainer Schimpf, Martin Borggrefe · 2020 · Definitions
57. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
    Steven I Estes, D. Ye, Wei Zhou, Steven M. Dotzler, D. Tester, J. Bos, C. John Kim, M. Ackerman · 2019 · Circulation Genomic and Precision Medicine
58. Recent advances in the treatment of Brugada syndrome
    M. Argenziano, C. Antzelevitch · 2018 · Expert Review of Cardiovascular Therapy
59. Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles
    Cun-Jin Luo, Kuan-Quan Wang, Heng-Gui Zhang · 2017 · Physiological Measurement
60. Short QT syndrome in pediatrics
    R. Pereira, Ó. Campuzano, G. Sarquella-Brugada, S. César, Anna Iglesias, J. Brugada, F. Cruz, R. Brugada · 2017 · Clinical Research in Cardiology
61. Quantifying the origins of population variability in cardiac electrical activity through sensitivity analysis of the electrocardiogram
    A. Sadrieh, Stefan A. Mann, R. Subbiah, L. Domanski, John A. Taylor, J. Vandenberg, A. Hill · 2013 · Journal of Physiology
62. Sudden cardiac arrest: Limitations in risk-stratification and treatment, and the potential for digital technologies and artificial intelligence to improve prediction and outcomes
    Sudarshan S Srivats, Fawzi Zghyer, Zaid Shahrori, Christine M. Albert, Sana M. Al‐Khatib, Sumeet S. Chugh, Susan P. Etheridge, Zachary D. Goldberger, Rakesh Gopinathannair, Dhanunjaya Lakkireddy et al. · 2025 · Progress in Cardiovascular Diseases
63. Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells
    Yingrui Li, Siegfried Lang, Ibrahim Akin, Xiaobo Zhou, Ibrahim El‐Battrawy · 2022 · Journal of the American Heart Association
64. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    T. Pambrun, Aurélie Mercier, A. Chatelier, S. Patri, J. Schott, S. Le Scouarnec, M. Chahine, B. Degand, P. Bois · 2014 · Heart Rhythm
65. Diagnosis and management of Brugada Syndrome.
    J. Vohra · 2011 · Heart, Lung and Circulation
66. Sodium channel blocker tests allow a clear distinction of electrophysiological characteristics and prognosis in patients with a type 2 or 3 Brugada electrocardiogram pattern.
    S. Evain, F. Briec, F. Kyndt, J. Schott, G. Lande, J. Albuisson, S. Abbey, H. Le Marec, V. Probst · 2008 · Heart Rhythm
67. Channelopathies in Children and Adults
    Arthur A.M. Wilde · 2008 · Pacing and Clinical Electrophysiology
68. Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndrome
    J. Hancox, C. Du, A. Butler, Y. Zhang, C. Dempsey, S. Harmer, H. Zhang · 2023 · Philosophical Transactions of the Royal Society of London. Biological Sciences
69. Palmitoylation of the pore-forming subunit of Ca(v)1.2 controls channel voltage sensitivity and calcium transients in cardiac myocytes
    Chien-Wen S. Kuo, Sara Dobi, Çağlar Gök, Ana Da Silva Costa, Alice Main, Olivia Robertson-Gray, Daniel Tomas Baptista‐Hon, Krzysztof J. Wypijewski, Hannah M. Costello, Tim G. Hales et al. · 2023 · Proceedings of the National Academy of Sciences
70. Preclinical short QT syndrome models: studying the phenotype and drug-screening
    Xuehui Fan, Guoqiang Yang, Jacqueline Kowitz, Fırat Duru, Ardan Muammer Saguner, İbrahim Akın, Xiaobo Zhou, Ibrahim El‐Battrawy · 2021 · EP Europace
71. Evaluating the Use of Genetics in Brugada Syndrome Risk Stratification
    M. Monasky, E. Micaglio, E. Locati, C. Pappone · 2021 · Frontiers in Cardiovascular Medicine
72. Sexual Dimorphisms, Anti-Hormonal Therapy and Cardiac Arrhythmias
    Virginie Grouthier, Melissa Moey, Estelle Gandjbakhch, Xavier Waintraub, Christian Funck‐Brentano, Anne Bachelot, Joe‐Elie Salem · 2021 · International Journal of Molecular Sciences
73. Susceptibility to Ventricular Arrhythmias Resulting from Mutations in FKBP1B, PXDNL, and SCN9A Evaluated in hiPSC Cardiomyocytes
    Héctor Barajas-Martínez, Maya Landenhed Smith, Dan Hu, Robert J. Goodrow, Colleen Puleo, Can Hasdemir, Charles N Antzelevitch, Ryan D. Pfeiffer, Jacqueline A. Treat, Jonathan M. Cordeiro · 2020 · Stem Cells International
74. Brugada syndrome in children - Stepping into unchartered territory
    S. Behere, S. Weindling · 2017 · Annals of Pediatric Cardiology
75. L-type Calcium Channel Cav1.2 Is Required for Maintenance of Auditory Brainstem Nuclei
    Lena Ebbers, Somisetty Venkata Satheesh, Katrin Janz, Lukas Rüttiger, Maren Blosa, Franz Bruno Hofmann, Markus Morawski, Désirée Griesemer, Marlies Knipper, Eckhard Friauf et al. · 2015 · Journal of Biological Chemistry
76. Arrhythmic substrate, slowed propagation and increased dispersion in conduction direction in the right ventricular outflow tract of murine Scn5a+/− hearts
    Y. Zhang, L. Guzadhur, K. Jeevaratnam, S. Salvage, G. D. K. Matthews, W. Lammers, M. Lei, L.-H. C. Huang, J. Fraser · 2014 · Acta Physiologica
77. Calcium channels as therapeutic targets
    Francesco Belardetti, Gerald Werner Zamponi · 2012 · Wiley Interdisciplinary Reviews Membrane Transport and Signalling
78. Role of genomics in cardiovascular medicine.
    G. Novelli, I. Predazzi, R. Mango, F. Romeo, J. Mehta · 2010 · World Journal of Cardiology
79. Phase-2 reentry in cardiac tissue: role of the slow calcium pulse.
    I. R. Cantalapiedra, A. Peñaranda, B. Echebarria, J. Bragard · 2010 · Physical review. E, Statistical, nonlinear, and soft matter physics
80. The Genetic and Clinical Features of Cardiac Channelopathies
    Jason D. Roberts, Michael H. Gollob · 2010 · Future Cardiology
81. Reexcitation mechanisms in epicardial tissue: role of I(to) density heterogeneities and I(Na) inactivation kinetics.
    I. R. Cantalapiedra, A. Peñaranda, L. Mont, J. Brugada, B. Echebarria · 2009 · Journal of Theoretical Biology
82. The role of CACNA1C in Brugada syndrome: prevalence and phenotype of probands referred for genetic testing.
    V. Novelli, M. Memmi, A. Malovini, A. Mazzanti, Nian Liu, Yan-Fei Ruan, R. Bongianino, M. Denegri, N. Monteforte, R. Bloise et al. · 2022 · Heart Rhythm
83. Personalized medicine in cardiovascular disease: review of literature
    Ali Sheikhy, Aida Fallahzadeh, Hamid Reza Aghaei Meybodi, Mandana Hasanzad, Masih Tajdini, Kaveh Hosseini · 2021 · Journal of Diabetes & Metabolic Disorders
84. Explaining sudden infant death with cardiac arrhythmias: Complete exon sequencing of nine cardiac arrhythmia genes in Dutch SIDS cases highlights new and known DNA variants.
    Germaine Liebrechts-Akkerman, Fan Liu, R. van Marion, W. Dinjens, M. Kayser · 2020 · Forensic Science International: Genetics
85. Sudden Cardiac Death in Brugada Syndrome
    Nitin K. Kabra, Rahul Gupta, W. Aronow, W. Frishman · 2019 · Cardiology in Review
86. Penetrance and expressivity of the R858H CACNA1C variant in a five‐generation pedigree segregating an arrhythmogenic channelopathy
    R. M. McKinlay Gardner, I. Crozier, Alex L. Binfield, Donald R. Love, K. Lehnert, K. Gibson, C. Lintott, R. G. Snell, J. Jacobsen, Peter P. Jones et al. · 2018 · Molecular Genetics & Genomic Medicine
87. J Wave Syndromes as a cause of Malignant Cardiac Arrhythmias
    J. D. Di Diego, C. Antzelevitch · 2018 · Pacing and clinical electrophysiology : PACE
88. Alternative Splicing at N Terminus and Domain I Modulates CaV1.2 Inactivation and Surface Expression.
    Peter Bartels, De-Jie Yu, Hua Huang, Zhenyu Hu, S. Herzig, T. Soong · 2018 · Biophysical Journal
89. Genetic analysis of sick sinus syndrome in a family harboring compound CACNA1C and TTN mutations
    Yao‐Bin Zhu, Jie-wei Luo, Fen Jiang, Gui Liu · 2018 · Molecular Medicine Reports
90. Modelling the effects of chloroquine on KCNJ2-linked short QT syndrome
    Cun-Jin Luo, Kuan-Quan Wang, Heng-Gui Zhang · 2017 · OncoTarget
91. Genetics update: Monogenetics, polygene disorders and the quest for modifying genes
    Joseph D. Symonds, Sameer M. Zuberi · 2017 · Neuropharmacology
92. Identification of Na+/K+-ATPase inhibition-independent proarrhythmic ionic mechanisms of cardiac glycosides
    Cai Hong Koh, Jianjun Wu, Ying Ying Chung, Zhenfeng Liu, Rongrong Zhang, Ketpin Chong, Vladimir P. Korzh, Sherwin Ting, Steve Oh, WINSTON S. N. SHIM et al. · 2017 · Scientific Reports
93. Brugada Phenocopy as a Dynamic Electrocardiographic Pattern during Acute Anterior Myocardial Infarction
    F. Ferrando-Castagnetto, Alejandra Garibaldi-Remuñan, G. Vignolo, R. Ricca-Mallada, A. Baranchuk · 2016 · Annals of Noninvasive Electrocardiology
94. The role of SNP-loop diuretic interactions in hypertension across ethnic groups in HyperGEN
    L. de las Fuentes, Yun J. Sung, K. Schwander, Sonia Kalathiveetil, S. Hunt, D. Arnett, Dabeeru C. Rao · 2013 · Frontiers in Genetics
95. A study of the SCN5A gene in a cohort of 76 patients with Brugada syndrome
    E. García-Molina, J. Lacunza, F. Ruíz-Espejo, M. Sabater, Arcadi García-Alberola, J. R. Gimeno, F. Cañizares, A. Garcia, P. Martínez, Mariano Valdés et al. · 2013 · Clinical Genetics
96. Ahnak1 modulates L-type Ca2+ channel inactivation of rodent cardiomyocytes
    J. Alvarez, D. Petzhold, Ines Pankonien, J. Behlke, Michiyoshi Kouno, G. Vassort, I. Morano, H. Haase · 2010 · Pflügers Archiv: European Journal of Physiology
97. Quinidine in Short QT Syndrome: An Old Drug for a New Disease
    Elizabeth S. Kaufman · 2007 · Cardiovascular Electrophysiology
98. The Brugada syndrome
    T. Rossenbacker, S. Priori · 2007 · Current Opinion in Cardiology
99. Genetic Causes of Cardiac Disease
    J. W. Knowles · 2019 · Cardiac and Vascular Biology
100. A new criteria differentiating type 2 and 3 Brugada patterns from ordinary incomplete right bundle branch block.
     Kimie Ohkubo, I. Watanabe, Y. Okumura, Sonoko Ashino, Masayoshi Kofune, K. Nagashima, T. Nakai, Satoshi Kunimoto, Y. Kasamaki, A. Hirayama · 2011 · International Heart Journal